5-Methylisoxazole-3-carboxylic acid, 98.0%, 500g

tert-Butyl 7-iodoheptanoate, 98%, 5g

Ethyl 5-methyl-1H-pyrazole-3-carboxylate, 97.0%, 10g

tert-Butyl 4-[(tetrahydro-2H-pyran-4-carbonyl)amino]piperidine-1-carboxylate, 95.0%, 1g

Benzenepropanoic acid, 5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(2,3-dihydro-3-oxo-1,2-benzisoxazol-6-yl)Methoxy]-, 5mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(((tert-butoxycarbonyl)amino)methyl)phenyl)propanoic acid, 97%, 1g

N-[3-(trifluoromethyl)phenyl]guanidine, 95.0%, 250mg

GC-Kapillarsäule ROTI®Cap-624, 25 m, 0.20 mm, 1.10 µm, mittelpolar, 1 Stück

4,7,10,13,16,19-HEXAOXA-22-AZAPENTACOSANOIC ACID, 25-(2,5-DIHYDRO-2,5-DIOXO-1H-PYRROL-1-YL)-23-OXO-, 2,5-DIOXO-1-PYRROLIDINYL ESTER, 95%, 5g

Ethyl 2-fluoro-4-methoxybenzoate, 97%, 1g

Ethyl 5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]-pyrimidine-6-carboxylate, 95.0%, 25g

GAMABUFOTALIN, 95%, 5mg

4-Phenyl-tetrahydro-pyran-4-ylamine, 95.0%, 500mg